20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1016L | Aviptadil Acetate | Vasoactive Intestinal Peptide acetate salt | RAAS , SARS-CoV |
Aviptadil Acetate (Vasoactive Intestinal Peptide acetate salt) induces pulmonary vasodilation and inhibits the proliferation of vascular SMCs and platelet aggregation. Avitadil acetate can be used for research on pulmona... | |||
T80866 | VIP(Guinea pig) TFA | Vasoactive Intestinal Peptide, guinea pig TFA | |
Vasoactive Intestinal Peptide (VIP) Guinea pig TFA, a trophic and mitogenic factor, promotes growth in cultured whole embryos and acts as a gastrointestinal hormone, while also indicating potential neurotransmitter funct... | |||
TP1016 | Aviptadil | Vasoactive Intestinal Peptide (human, rat, mouse, rabbit, canine, porcine) | |
Aviptadil (INN) is an analog of vasoactive intestinal polypeptide (VIP) for the treatment of erectile dysfunction. | |||
TP1627L | Prepro VIP (111-122), human acetate | Prepro VIP (111-122), human acetate(123025-94-5 free base) | Others |
Prepro VIP (111-122), human acetate is a prepro-vasoactive intestinal polypeptide (VIP)–derived peptide, corresponding to residues 111-122. | |||
TP2103L | [D-p-Cl-Phe6,Leu17]-VIP acetate | Others | |
[D-p-Cl-Phe6,Leu17]-VIP acetate is a competitive and selective antagonist of vasoactive intestinal peptide (VIP) receptor (IC50 = 125.8 nM). | |||
TP1283L | VIP(6-28)(human, rat, porcine, bovine) acetate | Others | |
VIP(6-28)(human, rat, porcine, bovine) acetate is an antagonist of the actions of exogenous vasoactive intestinal peptide (VIP) receptor on cAMP in the superior cervical ganglion (SCG). | |||
TP1283 | VIP(6-28)(human, rat, porcine, bovine) | ||
VIP(6-28)(human, rat, porcine, bovine) is a potent antagonist that effectively counteracts the effects of exogenous vasoactive intestinal peptide (VIP) on cyclic adenosine monophosphate (cAMP) signaling. | |||
T36635 | [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) | [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) | |
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) is an analog of GRF and a vasoactive intestinal peptide (VIP) antagonist. | |||
TP2103 | [D-p-Cl-Phe6,Leu17]-VIP | ||
Selective vasoactive intestinal peptide (VIP) receptor antagonist (IC50 = 125.8 nM). Displays no activity on glucagon, secretin or GRF receptors. | |||
TP1635 | Prepro VIP (81-122), human | ||
Prepro VIP (81-122), human is a prepro-vasoactive intestinal polypeptide (VIP) derived peptide, corresponding to residues 81-122. | |||
TP1627 | Prepro VIP (111-122), human | ||
Prepro VIP (111-122), human is a prepro-vasoactive intestinal polypeptide (VIP)–derived peptide, corresponding to residues 111-122. | |||
T83195 | Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) | ||
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP(1-7)-GRF(8-27) is a selective antagonist [1] for the vasoactive intestinal peptide 1 (VIP 1) receptor. | |||
TP1054 | PACAP (1-38), human, ovine, rat TFA | Pituitary Adenylate Cyclase Activating Polypeptide 38 (TFA) | |
PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP... | |||
T36428 | PACAP-related Peptide (human) (trifluoroacetate salt) | PACAP | |
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adeny... | |||
T80876 | Vasomera | ||
Vasomera, a stable, long-acting vasoactive intestinal peptide (VIP) agonist, targets G-protein-coupled VPAC2 receptors and is employed in the study of cardiomyopathy associated with dystrophinopathies [1]. | |||
T78003 | [D-p-Cl-Phe6,Leu17]-VIP TFA | ||
[D-p-Cl-Phe6,Leu17]-VIP TFA acts as a competitive and selective antagonist of the vasoactive intestinal peptide (VIP) receptor, exhibiting an IC50 of 125.8 nM. It shows no activity on glucagon, secretin, or growth hormon... | |||
T80069 | PACAP (6-27) (human, ovine, rat) | Pituitary adenylate cyclase-activating peptide (6-27) | |
PACAP (6-27) (human, ovine, rat) serves as an antagonist for the PACAP receptor, inhibiting the catecholamine response of the canine adrenal gland to vasoactive intestinal peptide (VIP). This compound holds promise for r... | |||
T82217 | Helospectin I | ||
Helospectin I, a neuropeptide belonging to the vasoactive intestinal peptide (VIP) family, exhibits vasodilatory and antihypertensive properties, effectively reducing blood pressure. It was initially isolated from the sa... | |||
T82216 | Helospectin II | ||
Helospectin II, a member of the vasoactive intestinal peptide (VIP) family, exhibits vasodilatory and antihypertensive properties that reduce blood pressure. This neuropeptide was initially isolated from the venom of the... | |||
T81571 | PACAP (1-38) free acid TFA | ||
PACAP (1-38) free acid TFA, an endogenous neuropeptide, effectively enhances antral motility and somatostatin secretion, while concurrently suppressing gastrin secretion and promoting the release of vasoactive intestinal... |